Naseem Amin - 31 Dec 2021 Form 4 Insider Report for Bellerophon Therapeutics, Inc. (BLPH)

Role
Director
Signature
/s/ Naseem Amin
Issuer symbol
BLPH
Transactions as of
31 Dec 2021
Net transactions value
+$26,880
Form type
4
Filing time
04 Jan 2022, 15:10:22 UTC
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLPH Common Stock Award $0 +39,032 +32% $0.000000 160,287 31 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLPH Stock Options (right to buy) Award $26,880 +8,671 +57% $3.10* 23,809 31 Dec 2021 Common Stock 8,671 $3.10 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RSAs fully vested on grant date.